Consider Our Overview Before Taking a Position in MNST

Large-cap Consumer Staples company Monster Beverage has logged a 0.9% change today on a trading volume of 1,315,126. The average volume for the stock is 4,400,604.

Monster Beverage Corporation, through its subsidiaries, engages in development, marketing, sale, and distribution of energy drink beverages and concentrates in the United States and internationally. Based in Corona, United States the company has 4,607 full time employees and a market cap of $60,699,299,840.

The company is now trading -7.27% away from its average analyst target price of $62.41 per share. The 24 analysts following the stock have set target prices ranging from $51.5 to $72.0, and on average give Monster Beverage a rating of buy.

Over the last 12 months MNST shares have declined by -36.0%, which represents a difference of -44.0% when compared to the S&P 500. The stock's 52 week high is $60.47 per share and its 52 week low is $42.8. With its net margins declining an average -3.9% over the last 6 years, Monster Beverage declining profitability gives us reason to believe its stock price will continue to underwhelm.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023-03-01 6,311,050 1,191,624 19 -24.0
2022-02-28 5,541,352 1,377,475 25 -19.35
2021-03-01 4,598,638 1,409,594 31 19.23
2020-02-28 4,200,819 1,107,835 26 0.0
2019-02-28 3,807,183 993,004 26 8.33
2018-03-01 3,369,045 820,678 24
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.